about
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesActivated Complement Factors as Disease Markers for SepsisDo antimicrobial peptides and complement collaborate in the intestinal mucosa?Pathophysiology, staging and therapy of severe sepsis in baboon modelsAlternative Complement Pathway Deregulation Is Correlated with Dengue SeverityThe relationship of interacting immunological components in dengue pathogenesisStructural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureusComplement: a key system for immune surveillance and homeostasisInnate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeComplement therapy in atypical haemolytic uraemic syndrome (aHUS).C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results.Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.Starvation alters the liver transcriptome of the innate immune response in Atlantic salmon (Salmo salar).Staphylococcus aureus SdrE captures complement factor H's C-terminus via a novel 'close, dock, lock and latch' mechanism for complement evasionReview: Complement and its regulatory proteins in kidney diseases.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.Complement System Part I - Molecular Mechanisms of Activation and Regulation.New insights of an old defense system: structure, function, and clinical relevance of the complement system.Role of complement in host-microbe homeostasis of the periodontium.Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl₄-induced injury.Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.A quantitative lateral flow assay to detect complement activation in bloodActivation of polymorphonuclear leukocytes by candidate biomaterials for an implantable glucose sensorThe alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathyAlternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement SystemA local complement response by RPE causes early-stage macular degeneration.Endothelial cells elicit immune-enhancing responses to dengue virus infection.Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity RelationshipsComplement-targeted therapeutics in periodontitisLocal release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement.Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis.MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linkedAdenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.
P2860
Q24632001-05D010D1-022E-4E04-876C-EFDDA8FFB3ADQ26784268-B2B0A7AC-4561-462E-A218-93A2F3D26AAAQ26865903-89A8224D-F57A-47CD-A7CA-4BDE69444E63Q27024559-6AA940B6-AB5C-42D1-A20B-3E1312A599E4Q27489374-DDB30A1A-E61D-464C-B383-78DD42AADC6EQ27490496-ADFDDF26-F61C-4436-8B89-BC4EFA8B0772Q27659556-0C6EDE5D-E74E-479C-AC2E-E87F4EB8D3D7Q29615484-AB6EAA37-B063-4CE8-BFCA-D5889576D081Q30244210-8C26381F-F1AC-47CB-9A2A-52FFE8A0CEAAQ33396792-66A23FAD-4C8C-404B-AFB6-E5A54E2B5327Q33408733-1A3C3D64-10E5-4945-96E2-3522E72C00D6Q33435310-674E8929-6E9A-4BF2-87A2-BCDC5F64F11FQ33436512-D9ED321E-B46C-4FC5-BA6C-D9D6C7638F48Q33613839-540C4C5C-455A-4B60-8DD6-9ED9437586CFQ33625464-FA73A1D3-306B-46F2-9846-3828D3DDA80CQ33634976-BCAEB6CC-BF40-41E9-ACC0-9707334E9C48Q33647738-A8E36ED9-C5BF-4825-955C-58B7016E7E86Q33852943-24C206AF-A425-4183-B6DB-573B6DA0B6A9Q34105747-19FCB74A-A1A8-4A1F-9541-795DF79D5EE3Q34162118-1FF90A0F-18FF-4072-8ED7-FA77F448EA74Q34481071-0B9CE501-68E7-4D46-80A2-75307BF8365FQ34699496-843291BF-9A8A-41CF-98AD-C079A1BE221AQ34727808-547FDAAC-CEAA-4E7A-92A2-44B4BB666360Q34809153-8146FB71-1132-4683-90D5-55B56085DE0AQ34993153-C438D7D7-3836-4862-A6FE-1B55B516FD51Q35127927-7F427CEA-3A3A-4CF4-8CB5-A99C993CE4C5Q35169360-8E5299EA-D962-4709-8944-52AB8EB6A45FQ35498749-8FF8196D-5D94-4565-9020-D46C6F5B5E8FQ35684979-E1E7B88F-0DBE-4C8E-A509-A7E92E850A3AQ35859558-0A227966-ABC7-454D-80D9-48B6D0F2D211Q35922386-16FAE763-000D-4170-9476-9B45C067E382Q35988440-87382703-D30E-4773-8CD5-E90CB4BED5E2Q36065466-F027D7A6-4307-4CAC-8277-39C04858DB99Q36086727-D6332721-BE2D-4C80-8890-7841D40B0772Q36175011-BA0372EF-1BA4-4167-A242-4209D0B10146Q36302901-206BB51D-7434-4205-8F59-C8080C1A8F4BQ36540594-CABD6151-CF54-4B5D-946A-BB3006187774Q36803645-D9A3AB6F-08FB-48D8-B8A0-03DB37F19C28Q37184863-0008712F-E7BE-4788-BF50-4CE712045B93Q37191878-C28040EA-0E1C-4424-809F-C5B9C9427374
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The alternative complement pathway revisited.
@en
The alternative complement pathway revisited.
@nl
type
label
The alternative complement pathway revisited.
@en
The alternative complement pathway revisited.
@nl
prefLabel
The alternative complement pathway revisited.
@en
The alternative complement pathway revisited.
@nl
P2860
P1476
The alternative complement pathway revisited.
@en
P2860
P304
P356
10.1111/J.1582-4934.2008.00350.X
P577
2008-04-15T00:00:00Z